This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
E-Therapeutics plc Announces Strategic Collaboration with Arcturis Data Limited CI
Cash-Strapped Sensyne Health to Lay Off Majority of Staff MT
Sensyne Health Slumps 32% on End of Formal Sale Process, Planned Delisting MT
Sensyne Health Ends Formal Sale Process With Expanded Note Purchase Agreement MT
Sensyne Health Names New CEO MT
Sensyne Health Announces Termination of the Formal Sale Process CI
Sensyne Health Plummets 85% Amid CEO Change, Revised Financing Deal MT
Sensyne Health Remains In Talks With Potential Buyers Amid Funding Increase To Continue Operating MT
Sensyne Health CEO Steps Down; Successor Appointed MT
Sensyne Health plc Announces Executive Changes CI
Shares in Sensyne Dive After It Warns on Future, Amends Financing Agreement DJ
Sensyne Health Issues New Shares To US Health Systems As Part Of Strategic Research Agreements MT
Sensyne Health plc Announces Change in Registered Office CI
Sensyne Health Issues Equity to Great Ormond Street Hospital for Children MT
FTSE Flat, Activist Chatter Puts Vodafone Among FTSE 100 Leaders DJ
Sensyne Health plc Reports Earnings Results for the Half Year Ended October 31, 2021 CI
Sensyne Health plc Announces Successful Completion of Financing CI
Sensyne Health plc announced that it expects to receive £11.35 million in funding CI
Sensyne Health CEO Mulls Delisting From London's AIM Segment MT
FTSE 100 Closes 0.3% Lower as Royal Mail, B&M Plummet DJ
FTSE Falls, Sterling Seen in Stable Range Vs Dollar in 2022 DJ
FTSE Down, GDP Data Seen Supporting Rate-Rise Bets But Pound Little Moved DJ
Sensyne Health Down 67% As Formal Sale Process Moves Forward MT
London Shares Edge Lower After Downbeat Asia Trading DJ
Sensyne & Rwhealth Announces Sensight Partnership CI
Chart Sensyne Health plc
More charts
Sensyne Health plc is a United Kingdom-based clinical artificial intelligence company. The Company offers SENSIGHT platform, which provides a research environment for pharmaceutical and life science companies to analyze deidentified and anonymized patient data to support all stages of research and development. The Company applies clinical artificial intelligence (AI) in the healthcare and life science industries. In healthcare, the Company delivers remote patient monitoring and real-time decision-making systems for healthcare organizations and their patients. In life sciences, the Company analyses anonymized data sets to help life sciences companies to develop medicines. The Company's healthcare products include a variety of applications, including decision-making support, remote patient monitoring, diagnostics, prescribed digital therapeutics and the recording and presentation of healthcare data in a clinical setting.
More about the company
  1. Stock Market
  2. Equities
  3. SENS Stock
  4. News Sensyne Health plc
  5. Sensyne Health Agrees To Fine Settlement With London Stock Exchange